Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery

被引:15
作者
Hamada, Y [1 ]
Kawachi, K [1 ]
Nakata, T [1 ]
Kohtani, T [1 ]
Takano, S [1 ]
Tsunooka, N [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Surg 2, Shigenobu, Ehime 7910295, Japan
关键词
open heart surgery; coronary artery bypass surgery; cardiopulmonary bypass; inflammatory response;
D O I
10.1046/j.1525-1594.2001.06754.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cardiac surgery with cardiopulmonary bypass is associated with a systemic inflammatory response. We examined combined use of heparin coating of the cardiopulmonary bypass circuit and a leukocyte-depleting arterial line filter to reduce this response. Thirty patients were allocated randomly to equal groups with a conventional circuit and arterial line filter (C group), a heparin-coated circuit with a conventional filter (H group), or a heparin-coated circuit with a leukocyte-depleting arterial line filter (HF group). Cytokines and respiratory function were repeatedly measured perioperatively. Plasma interleukin (IL)-6 concentrations in the HF group were lower than in the C group immediately following bypass and operation, at 4 h, and 12 h (p < 0.05). Plasma IL-8 was lower in the HF group than in the C group at 4 h (p < 0.05). The respiratory index was lower immediately after bypass in the HF group than the C group (0.61 +/- 0.2 versus 1.05 +/- 0.4, p < 0.05). Heparin-coated circuits with leukocyte-depleting filters decrease inflammatory responses and improve pulmonary function during operation.
引用
收藏
页码:1004 / 1008
页数:5
相关论文
共 23 条
  • [1] OUR EXPERIENCE WITH USING THE PALL LG6 LEUKOCYTE DEPLETING FILTER DURING CARDIOPULMONARY BYPASS
    ALEBRAHIM, K
    SHAFEI, H
    [J]. ANNALS OF THORACIC SURGERY, 1993, 56 (05) : 1216 - 1217
  • [2] Leucocyte depletion in cardiothoracic surgery
    Allen, S. M.
    [J]. PERFUSION-UK, 1996, 11 (03): : 270 - 277
  • [3] Inflammatory response after coronary revascularization with or without cardiopulmonary bypass
    Ascione, R
    Lloyd, CT
    Underwood, MJ
    Lotto, AA
    Pitsis, AA
    Angelini, GD
    [J]. ANNALS OF THORACIC SURGERY, 2000, 69 (04) : 1198 - 1204
  • [4] BANDO K, 1990, J THORAC CARDIOV SUR, V99, P873
  • [5] BOONSTRA PW, 1994, J THORAC CARDIOV SUR, V107, P289
  • [6] Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury
    Boyle, EM
    Kovacich, JC
    Hèbert, CA
    Canty, TG
    Chi, E
    Morgan, EN
    Pohlman, TH
    Verrier, ED
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (01) : 114 - 120
  • [7] INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
    BUTLER, J
    ROCKER, GM
    WESTABY, S
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (02) : 552 - 559
  • [8] Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration
    Defraigne, JO
    Pincemail, J
    Larbuisson, R
    Blaffart, F
    Limet, R
    [J]. ANNALS OF THORACIC SURGERY, 2000, 69 (04) : 1084 - 1091
  • [9] Inflammatory response to cardiopulmonary bypass
    Edmunds, LH
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (05) : S12 - S16
  • [10] Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes in fully heparinized patients: A European multicentre study
    Fosse, E
    Thelin, S
    Svennevig, JL
    Jansen, P
    Mollnes, TE
    Hack, E
    Venge, P
    Moen, O
    Brockmeier, V
    Dregelid, E
    Halden, E
    Hagman, L
    Videm, V
    Pedersen, T
    Mohr, B
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (02) : 320 - 327